A7851612
1,2,3,4-Tetrahydroisoquinoline , ≥95% , 91-21-4
CAS NO.:91-21-4
Empirical Formula: C9H11N
Molecular Weight: 133.19
MDL number: MFCD00006896
EINECS: 202-050-0
| Pack Size | Price | Stock | Quantity |
| 5G | RMB54.40 | In Stock |
|
| 25G | RMB174.40 | In Stock |
|
| 100G | RMB479.20 | In Stock |
|
| 500G | RMB2239.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | −30 °C(lit.) |
| Boiling point: | 232-233 °C(lit.) |
| Density | 1.064 g/mL at 25 °C(lit.) |
| vapor pressure | 3.33-97.9Pa at 20-58.5℃ |
| refractive index | n |
| Flash point: | 210 °F |
| storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
| solubility | 20g/l |
| form | Liquid |
| pka | 9.66±0.20(Predicted) |
| color | Clear yellow to brown |
| Water Solubility | Soluble in water at 20°C 20g/L. |
| BRN | 116156 |
| InChI | 1S/C9H11N/c1-2-4-9-7-10-6-5-8(9)3-1/h1-4,10H,5-7H2 |
| InChIKey | UWYZHKAOTLEWKK-UHFFFAOYSA-N |
| SMILES | C1Cc2ccccc2CN1 |
| CAS DataBase Reference | 91-21-4(CAS DataBase Reference) |
| EPA Substance Registry System | Isoquinoline, 1,2,3,4-tetrahydro- (91-21-4) |
Description and Uses
1,2,3,4-Tetrahydroisoquinoline is used as a reagent in the preparation of 4-(1,2,4-oxadiazol-5-yl)piperidine-1-carboxamides as antiproliferative tubulin inhibitors.
Safety
| Symbol(GHS) | ![]() ![]() ![]() GHS05,GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301-H310-H314-H332-H371-H412 |
| Precautionary statements | P260-P273-P280-P303+P361+P353-P304+P340+P310-P305+P351+P338 |
| PPE | Eyeshields, Gloves, type ABEK (EN14387) respirator filter |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| RTECS | NX4900000 |
| Hazard Note | Irritant |
| TSCA | TSCA listed |
| HS Code | 29334900 |
| Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2 very toxic hazardous materials |
| Hazard Classifications | Acute Tox. 2 Dermal Acute Tox. 3 Oral Acute Tox. 4 Inhalation Aquatic Chronic 3 Eye Dam. 1 Skin Corr. 1B STOT SE 2 |








